pI: 8.4949 |
Length (AA): 720 |
MW (Da): 79858 |
Paralog Number:
0
Signal peptide: Y | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128359)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G16660 | heat shock protein 70 |
Babesia bovis | BBOV_I003640 | DnaK family domain containing protein |
Brugia malayi | Bm1_39345 | dnaK protein |
Candida albicans | CaO19.5830 | translocation of protein precursors across ER |
Candida albicans | CaO19.13252 | translocation of protein precursors across ER |
Caenorhabditis elegans | CELE_T14G8.3 | Protein T14G8.3, isoform A |
Caenorhabditis elegans | CELE_T24H7.2 | Protein T24H7.2 |
Cryptosporidium hominis | Chro.20349 | HSP protein |
Cryptosporidium parvum | cgd2_3330 | APG-1 like HSP70 domain containing protein, signal peptide plus likely ER retention motif |
Dictyostelium discoideum | DDB_G0273093 | heat shock protein 70 family member |
Dictyostelium discoideum | DDB_G0273813 | heat shock protein 70 family member |
Drosophila melanogaster | Dmel_CG2918 | CG2918 gene product from transcript CG2918-RB |
Echinococcus granulosus | EgrG_000981800 | Heat shock protein Hsp70 |
Entamoeba histolytica | EHI_148990 | heat shock protein 70, putative |
Echinococcus multilocularis | EmuJ_000981800 | Heat shock protein Hsp70 |
Homo sapiens | ENSG00000149428 | hypoxia up-regulated 1 |
Leishmania braziliensis | LbrM.34.4680 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_354780.1 | Hsp70 protein, putative |
Leishmania infantum | LinJ.35.4780 | hypothetical protein, conserved |
Leishmania major | LmjF.35.4710 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.34.4710 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_02797 | dnaK protein |
Mus musculus | ENSMUSG00000032115 | hypoxia up-regulated 1 |
Neospora caninum | NCLIV_046170 | Heat Shock Protein 70, ER lumen, related |
Oryza sativa | 4330492 | Os02g0710900 |
Plasmodium berghei | PBANKA_1357200 | heat shock protein 110, putative |
Plasmodium falciparum | PF3D7_1344200 | heat shock protein 110, putative |
Plasmodium knowlesi | PKNH_1257200 | heat shock protein 110, putative |
Plasmodium vivax | PVX_083105 | heat shock protein 110, putative |
Plasmodium yoelii | PY05402 | putative HSP protein |
Saccharomyces cerevisiae | YKL073W | Hsp70 family chaperone LHS1 |
Schistosoma japonicum | Sjp_0060680 | ko:K09486 hypoxia up-regulated 1, putative |
Schistosoma mansoni | Smp_088950 | hypothetical protein |
Schmidtea mediterranea | mk4.000709.08 | Hypoxia up-regulated protein 1 |
Schmidtea mediterranea | mk4.000785.07 | Hypoxia up-regulated protein 1 |
Trypanosoma brucei gambiense | Tbg972.9.5670 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.9.9860 | 170 kDa glucose-regulated protein, putative |
Trypanosoma cruzi | TcCLB.508457.20 | Hsp70 protein, putative |
Trypanosoma cruzi | TcCLB.506885.440 | Hsp70 protein, putative |
Toxoplasma gondii | TGME49_226830 | DnaK family protein |
Theileria parva | TP01_0479 | dnaK domain protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.211.1390 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.1390 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.1390 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb09.211.1390 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_1357200 | Plasmodium berghei | Essential | plasmo |
TGME49_226830 | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Bos taurus | Heat shock cognate 71 kDa protein | 650 aa | 23.8% | 685 aa | Compounds | References |
1 literature reference was collected for this gene.